Concepedia
Kidney International · 2005 · 72 citations · 41 references
Open access
MedicineNephrologyPharmacotherapyDiabetologyRenal PathophysiologyRenal PharmacotherapyDiabetic Kidney DiseaseDiabetic NephropathyRenal DiseaseRenal ImpairmentRenal PharmacologyRenal ProtectionRenoprotective Therapies
41
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
BMJ · 1998 · 6.7K citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +16
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text
Medicine, Nephrology, Pharmacology +16
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
Edmund J. Lewis, Lawrence G. Hunsicker, Raymond P. Bain et al. · New England Journal of Medicine · 1993 · 5.4K citations
Medicine, Nephrology, Pharmacology +13
M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 4.8K citations